Louis Kuritzky
Family Medicine · Gainesville, FLNPI 1487686853
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Roche Molecular Systems, Inc. accounts for 61.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $50,052 and has fallen 78.9% since, to $10,568 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $1328.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Molecular Systems, Inc.$113K
- Lilly USA, LLC$20K
- Optinose US, Inc.$16K
- Abbott$9K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Boehringer Ingelheim$5K
- plus $16K from 14 others
Across 3 payments — averaging $2446.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$7K
What the payments were for
- Consulting fees$99,90454%
- Speaking & faculty fees$74,18540%
- Travel & lodging$7,9534%
- Food & beverage$2,3861%
- Education$1,5151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Molecular Systems, Inc. | 15 | $113,383 |
| Lilly USA, LLC | 62 | $19,763 |
| Optinose US, Inc. | 21 | $15,517 |
| Abbott | 3 | $9,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $6,391 |
| Boehringer Ingelheim | 6 | $5,497 |
| Lundbeck LLC | 2 | $4,550 |
| Eisai Inc. | 1 | $3,480 |
| Sanofi-aventis U.S. LLC | 4 | $3,338 |
| Eli Lilly | 2 | $2,275 |
| Pfizer | 1 | $2,250 |
| Novo Nordisk | 1 | $299 |
| Inspire Medical Systems, Inc. | 3 | $54 |
| Amgen | 2 | $29 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Boston Scientific | 1 | $23 |
| Gilead | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- cobas Influenza A/B Nucleic acid test for use on the cobas Liat System$27,571
- MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT$18,000
- cobas 4800 CT/NG Test v2.0$18,000
- Xhance$15,290
- VYVANSE$6,134
- JARDIANCE$5,422
- NORTHERA$4,550
- FreeStyle Libre$4,000
- Dayvigo$3,480
- NURTEC ODT$2,250
- TOUJEO$1,016
How this compares
$185,943 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gainesville
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Emily HornTampa$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.